ID
22639
Beskrivning
Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus
Nyckelord
Versioner (1)
- 2017-06-08 2017-06-08 -
Rättsinnehavare
Genentech, Inc.
Uppladdad den
8 juni 2017
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
STUDY EYE SELECTION (SCREENING) CRFs Roche FVF4170G Macular Edema NCT-Nummer: NCT00473382
STUDY EYE SELECTION (SCREENING) CRFs Roche FVF4170G Macular Edema NCT-Nummer: NCT00473382
Beskrivning
Eligibility Criteria
Beskrivning
ELIGIBILITY_CRITERIA
Datatyp
integer
Alias
- UMLS CUI [1,1]
- C0681850
- UMLS CUI [1,2]
- C0015392
Beskrivning
EYE_PROTOCOL
Datatyp
boolean
Alias
- UMLS CUI [1,1]
- C1457868
- UMLS CUI [1,2]
- C1690532
Beskrivning
REASON
Datatyp
text
Alias
- UMLS CUI [1]
- C0392360
Similar models
STUDY EYE SELECTION (SCREENING) CRFs Roche FVF4170G Macular Edema NCT-Nummer: NCT00473382
C2986440 (UMLS CUI [1,2])
C0015392 (UMLS CUI [1,2])
C1690532 (UMLS CUI [1,2])